ResourceLife Sciences
Biomarkers in Metabolic Syndrome
14 Nov 2017This white paper highlights a potential application for LGCs Biomarker Testing Service. It discusses utilizing biomarkers in the study of metabolic syndrome, which leads to an increased risk of Cardiovascular Disease and Type 2 Diabetes.
Related Products
Request Quote for All Products
Biomarker testing service
ResolianBiomarker strategy is critical to success. Our personalized biomarker solutions help drive your development to market. The expert biomarker teams support non-clinical and clinical biomarker method development, validation, and sample analysis.